{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:24:57Z","timestamp":1768451097810,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12105-017-0855-5","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T07:35:57Z","timestamp":1507102557000},"page":"274-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications"],"prefix":"10.1007","volume":"12","author":[{"given":"Bin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Aryeequaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Katabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"855_CR1","volume-title":"World Health Organization classification of tumours: pathology and genetics of head and neck tumours","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. 4th ed. Lyon: IARC Press; 2017.","edition":"4"},{"issue":"5","key":"855_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","volume":"34","author":"A Skalova","year":"2010","unstructured":"Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599\u2013608. doi:\n                    10.1097\/PAS.0b013e3181d9efcc\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"855_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/gcc.20881","volume":"50","author":"CR Antonescu","year":"2011","unstructured":"Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50(7):559\u201370. doi:\n                    10.1002\/gcc.20881\n                    \n                  .","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"855_CR4","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ng.3096","volume":"46","author":"I Weinreb","year":"2014","unstructured":"Weinreb I, Piscuoglio S, Martelotto LG, Waggott D, Ng CK, Perez-Ordonez B, et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat Genet. 2014;46(11):1166\u20139. doi:\n                    10.1038\/ng.3096\n                    \n                  .","journal-title":"Nat Genet"},{"issue":"10","key":"855_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/hed.23485","volume":"36","author":"MK Bhayani","year":"2014","unstructured":"Bhayani MK, Yilmaz T, Sweeney A, Calzada G, Roberts DB, Levine NB, et al. Sinonasal adenocarcinoma: a 16-year experience at a single institution. Head Neck. 2014;36(10):1490\u20136. doi:\n                    10.1002\/hed.23485\n                    \n                  .","journal-title":"Head Neck"},{"issue":"3","key":"855_CR6","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms14035170","volume":"14","author":"V Szablewski","year":"2013","unstructured":"Szablewski V, Solassol J, Poizat F, Larrieux M, Crampette L, Mange A, et al. EGFR expression and KRAS and BRAF mutational status in intestinal-type sinonasal adenocarcinoma. Int J Mol Sci. 2013;14(3):5170\u201381. doi:\n                    10.3390\/ijms14035170\n                    \n                  .","journal-title":"Int J Mol Sci"},{"issue":"6","key":"855_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s13402-012-0103-7","volume":"35","author":"C Garcia-Inclan","year":"2012","unstructured":"Garcia-Inclan C, Lopez F, Perez-Escuredo J, Cuesta-Albalad MP, Vivanco B, Centeno I, et al. EGFR status and KRAS\/BRAF mutations in intestinal-type sinonasal adenocarcinomas. Cell Oncol. 2012;35(6):443\u201350. doi:\n                    10.1007\/s13402-012-0103-7\n                    \n                  .","journal-title":"Cell Oncol"},{"issue":"3","key":"855_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.anndiagpath.2010.10.002","volume":"15","author":"F Bhaijee","year":"2011","unstructured":"Bhaijee F, Carron J, Bell D. Low-grade nonintestinal sinonasal adenocarcinoma: a diagnosis of exclusion. Ann Diagn Pathol. 2011;15(3):181\u20134. doi:\n                    10.1016\/j.anndiagpath.2010.10.002\n                    \n                  .","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"855_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12105-016-0694-9","volume":"10","author":"I Leivo","year":"2016","unstructured":"Leivo I. Sinonasal adenocarcinoma: update on classification, immunophenotype and molecular features. Head Neck Pathol. 2016;10(1):68\u201374. doi:\n                    10.1007\/s12105-016-0694-9\n                    \n                  .","journal-title":"Head Neck Pathol"},{"issue":"3","key":"855_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-014-1701-8","volume":"466","author":"H Majewska","year":"2015","unstructured":"Majewska H, Skalova A, Stodulski D, Klimkova A, Steiner P, Stankiewicz C, et al. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Virchows Arch. 2015;466(3):245\u201354. doi:\n                    10.1007\/s00428-014-1701-8\n                    \n                  .","journal-title":"Virchows Arch"},{"issue":"1","key":"855_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAS.0000000000000537","volume":"40","author":"A Skalova","year":"2016","unstructured":"Skalova A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, et al. Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion. Am J Surg Pathol. 2016;40(1):3\u201313. doi:\n                    10.1097\/PAS.0000000000000537\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"855_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/his.12702","volume":"67","author":"E Lurquin","year":"2015","unstructured":"Lurquin E, Jorissen M, Debiec-Rychter M, Hermans R, Hauben E. Mammary analogue secretory carcinoma of the sinus ethmoidalis. Histopathology. 2015;67(5):749\u201351. doi:\n                    10.1111\/his.12702\n                    \n                  .","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"855_CR13","doi-asserted-by":"publisher","first-page":"S30-6","DOI":"10.1007\/s12105-013-0455-y","volume":"7","author":"A Skalova","year":"2013","unstructured":"Skalova A. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity. Head Neck Pathol. 2013;7(Suppl 1):S30-6. doi:\n                    10.1007\/s12105-013-0455-y\n                    \n                  .","journal-title":"Head Neck Pathol"},{"issue":"1","key":"855_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAS.0b013e318231542a","volume":"36","author":"A Connor","year":"2012","unstructured":"Connor A, Perez-Ordonez B, Shago M, Skalova A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36(1):27\u201334. doi:\n                    10.1097\/PAS.0b013e318231542a\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"855_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/modpathol.2013.84","volume":"27","author":"A Pinto","year":"2014","unstructured":"Pinto A, Nose V, Rojas C, Fan YS, Gomez-Fernandez C. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics. Mod Pathol. 2014;27(1):30\u20137. doi:\n                    10.1038\/modpathol.2013.84\n                    \n                  .","journal-title":"Mod Pathol"},{"issue":"8","key":"855_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/modpathol.2015.64","volume":"28","author":"TM Stevens","year":"2015","unstructured":"Stevens TM, Kovalovsky AO, Velosa C, Shi Q, Dai Q, Owen RP, et al. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study. Mod Pathol. 2015;28(8):1084\u2013100. doi:\n                    10.1038\/modpathol.2015.64\n                    \n                  .","journal-title":"Mod Pathol"},{"issue":"4","key":"855_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/jop.12226","volume":"44","author":"F Projetti","year":"2015","unstructured":"Projetti F, Lacroix-Triki M, Serrano E, Vergez S, Barres BH, Meilleroux J, et al. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma? J Oral Pathol Med. 2015;44(4):244\u201351. doi:\n                    10.1111\/jop.12226\n                    \n                  .","journal-title":"J Oral Pathol Med"},{"key":"855_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000912","author":"S Andreasen","year":"2017","unstructured":"Andreasen S, Skalova A, Agaimy A, Bishop JA, Laco J, Leivo I, et al. ETV6 gene rearrangements characterize a morphologically distinct subset of sinonasal low-grade non-intestinal-type adenocarcinoma: a novel translocation-associated carcinoma restricted to the sinonasal tract. Am J Surg Pathol. 2017. doi:\n                    10.1097\/PAS.0000000000000912\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"855_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/lary.24254","volume":"124","author":"R Sethi","year":"2014","unstructured":"Sethi R, Kozin E, Remenschneider A, Meier J, VanderLaan P, Faquin W, et al. Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope. 2014;124(1):188\u201395. doi:\n                    10.1002\/lary.24254\n                    \n                  .","journal-title":"Laryngoscope"},{"issue":"12","key":"855_CR20","first-page":"9008","volume":"7","author":"W Luo","year":"2014","unstructured":"Luo W, Lindley SW, Lindley PH, Krempl GA, Seethala RR, Fung KM. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature. Int J Clin Exp Pathol. 2014;7(12):9008\u201322.","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"855_CR21","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/pbc.26026","volume":"63","author":"R Nagasubramanian","year":"2016","unstructured":"Nagasubramanian R, Wei J, Gordon P, Rastatter JC, Cox MC, Pappo A. Infantile fibrosarcoma with NTRK3-ETV6 fusion successfully treated with the tropomyosin-related kinase inhibitor LOXO-101. Pediatr Blood Cancer. 2016;63(8):1468\u201370. doi:\n                    10.1002\/pbc.26026\n                    \n                  .","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"855_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/annonc\/mdw042","volume":"27","author":"A Drilon","year":"2016","unstructured":"Drilon A, Li G, Dogan S, Gounder M, Shen R, Arcila M, et al. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC). Ann Oncol. 2016;27(5):920\u20136. doi:\n                    10.1093\/annonc\/mdw042\n                    \n                  .","journal-title":"Ann Oncol"},{"issue":"4","key":"855_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1158\/1535-7163.MCT-15-0758","volume":"15","author":"E Ardini","year":"2016","unstructured":"Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications. Mol Cancer Ther. 2016;15(4):628\u201339. doi:\n                    10.1158\/1535-7163.MCT-15-0758\n                    \n                  .","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"855_CR24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1517\/13543784.2015.1096344","volume":"24","author":"C Rolfo","year":"2015","unstructured":"Rolfo C, Ruiz R, Giovannetti E, Gil-Bazo I, Russo A, Passiglia F, et al. Entrectinib: a potent new TRK, ROS1, and ALK inhibitor. Expert Opin Investig Drugs. 2015;24(11):1493\u2013500. doi:\n                    10.1517\/13543784.2015.1096344\n                    \n                  .","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"855_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/2159-8290.CD-15-0443","volume":"5","author":"RC Doebele","year":"2015","unstructured":"Doebele RC, Davis LE, Vaishnavi A, Le AT, Estrada-Bernal A, Keysar S, et al. An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101. Cancer Discov. 2015;5(10):1049\u201357. doi:\n                    10.1158\/2159-8290.CD-15-0443\n                    \n                  .","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"855_CR26","doi-asserted-by":"publisher","first-page":"S37-47","DOI":"10.1007\/s12105-013-0458-8","volume":"7","author":"T Nagao","year":"2013","unstructured":"Nagao T. \u201cDedifferentiation\u201d and high-grade transformation in salivary gland carcinomas. Head Neck Pathol. 2013;7(Suppl 1):S37-47. doi:\n                    10.1007\/s12105-013-0458-8\n                    \n                  .","journal-title":"Head Neck Pathol"},{"issue":"1","key":"855_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","volume":"38","author":"A Skalova","year":"2014","unstructured":"Skalova A, Vanecek T, Majewska H, Laco J, Grossmann P, Simpson RH, et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38(1):23\u201333. doi:\n                    10.1097\/PAS.0000000000000088\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"855_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4132\/KoreanJPathol.2013.47.1.36","volume":"47","author":"MJ Jung","year":"2013","unstructured":"Jung MJ, Song JS, Kim SY, Nam SY, Roh JL, Choi SH, et al. Finding and characterizing mammary analogue secretory carcinoma of the salivary gland. Korean J Pathol. 2013;47(1):36\u201343. doi:\n                    10.4132\/KoreanJPathol.2013.47.1.36\n                    \n                  .","journal-title":"Korean J Pathol"},{"key":"855_CR29","doi-asserted-by":"publisher","unstructured":"Cipriani NA, Blair EA, Finkle J, Kraninger JL, Straus CM, Villaflor VM, et al. Salivary gland secretory carcinoma with high-grade transformation, CDKN2A\/B loss, distant metastasis, and lack of sustained response to crizotinib. Int J Surg Pathol. 2017. doi:\n                    10.1177\/1066896917709350\n                    \n                  .","DOI":"10.1177\/1066896917709350"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-017-0855-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-017-0855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-017-0855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:07:24Z","timestamp":1589735244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-017-0855-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1007\/s12105-017-0855-5","relation":{},"ISSN":["1936-055X","1936-0568"],"issn-type":[{"value":"1936-055X","type":"print"},{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"assertion":[{"value":"6 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that he\/she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}